Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

P38 MAP kinase is activated at early stages in Alzheimer's disease brain

Sun, A · 2003 · Experimental Neurology

Abstract

The regional, cellular, and subcellular localization of phosphorylated p38 MAPK (pp38) was examined by immunocytochemistry, immuofluorescent multiple labeling, and immunoblotting of extracts as well as immunoprecipitates of human postmortem tissue from control and Alzheimer's disease (AD) cases at different Braak stages. "Early AD" cases (Braak stages IV-V) and a subset of Braak stage VI cases have high levels of pp38 immunoreactivity, with the most dense immunoreactivity located in CA2 and subiculum followed by CA1 in the hippocampus. On the contrary, very little pp38 was detected in age-matched controls (Braak stages 0-II). More importantly, as revealed by various multiple labeling experiments, pp38 immunoreactivity is mainly located in neurons bearing early neurofibrillary pathology, but not in typically fibrillar tangles that are densely stained by thioflavin-S. Most pp38-positive neurons only contain a small amount of phospho-tau. Additionally, pp38 immunoreactivity was not associated with senile plaques. At the subcellular level, pp38-immunoreactive granules are usually larger than the granules stained with the lysosomal marker cathepsin D. Immunoblotting with different extraction buffers and immunoprecipitation indicate that pp38 does not or only loosely binds to phospho-tau. Taken together, this study demonstrates that p38 MAPK is activated at early stages of neurofibrillary degeneration in AD hippocampus. The p38 activation may also be linked to neurodegeneration thr…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0014-4886(03)00180-8

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Cited by

See all 221

Metadata

Authors
Sun, A.
Affiliations
University of Kentucky (US)
Corresponding author
Sun, A
ORCID
Sun, A
Venue
Experimental Neurology
Publisher
Elsevier BV
Published
2003-10
Volume
183
Issue
2
Pages
394-405
ISSN
0014-4886 (ISSN-L)
OpenAlex
W2081858180
Cited by
219
References
35
Citations by year
2026: 9 · 2025: 9 · 2024: 14 · 2023: 16 · 2022: 11 · 2021: 14 · 2020: 21 · 2019: 11 · 2018: 9 · 2017: 13 · 2016: 6 · 2015: 5 · 2014: 8 · 2013: 9 · 2012: 9
Type
conference abstract
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Experimental Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ns039345-04)
  • National Institute of Neurological Disorders and Stroke (3R01 NS 39345-01)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
p38 MAPK, Alzheimer's disease, neurofibrillary tangles, Braak stages, hippocampus, CA2, subiculum, CA1, phosphorylated tau, amyloid plaques, neurodegeneration, postmortem brain, subcellular localization, lysosomal granules, cathepsin D
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Brain, Enzyme Activation, Hippocampus, Humans, Middle Aged, Neurons, Parietal Lobe, Phosphorylation, Precipitin Tests, Neurofibrillary Tangles, tau Proteins, Disease Progression, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: P38 MAP kinase is activated at early stages in Alzheimer's disease brain. https://app.cochat.ai/papers/10.1016/s0014-4886(03)00180-8
The paper
Sun, A. (2003). P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Experimental Neurology. https://doi.org/10.1016/s0014-4886(03)00180-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.